Kaleido Biosciences, Inc.KLDOOTCMARKET
Loading
Year-over-year SG&A expense growth
| Period | Value |
|---|---|
| Q4 2021 | -9.58% |
| Q3 2021 | -11.74% |
| Q2 2021 | 5.95% |
| Q1 2021 | 4.90% |
| Q4 2020 | -27.72% |
| Q3 2020 | 29.54% |
| Q2 2020 | -6.05% |
| Q1 2020 | 21.10% |
| Q4 2019 | -17.61% |
| Q3 2019 | -4.06% |
| Q2 2019 | 13.77% |
| Q1 2019 | -2.93% |
| Q4 2018 | -21.65% |
| Q3 2018 | 122.55% |
| Q2 2018 | 20.22% |
| Q1 2018 | 8.54% |
| Q4 2017 | 0.00% |